Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · IEX Real-Time Price · USD
0.960
+0.029 (3.13%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $173.45 million as of July 26, 2024. Its market cap has decreased by -8.23% in one year.
Market Cap
173.45M
Enterprise Value
161.22M
1-Year Change
-8.23%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has increased from $30.70M to $173.45M, an increase of 464.97%. That is a compound annual growth rate of 27.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 168.20M | 39.93% |
| Dec 29, 2023 | 120.20M | 4.07% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TruBridge | 171.08M |
| FibroBiologics | 170.38M |
| Innate Pharma | 169.18M |
| Kodiak Sciences | 169.16M |
| Stereotaxis | 168.59M |
| Achieve Life Sciences | 167.93M |
| Adverum Biotechnologies | 167.92M |
| INmune Bio | 167.56M |